← Back

$ Value

$79K

Shares

3,859

Price

$20

Filed

Feb 4

Insider

Name

SMITH NATHAN

Title

Chief Financial Officer

CIK

0002079385

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

79,016

Footnotes

The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date. | The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human Capital Committee of the Issuer's Board of Directors on February 2, 2026. | These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.

Filing Info

Accession No.

0002079385-26-000001

Form Type

4

Issuer CIK

0001217234

SMITH NATHAN's History

Date Ticker Type Value
2026-02-02 CDNA A $0
2026-02-02 CDNA A $0
2026-02-02 CDNA F $79K
2025-08-07 CDNA A $0

Other Insiders at CDNA (90d)

Insider Bought Sold Last
Goldberg Michael 2026-04-02
Kennedy Keith
CFO & COO
2026-04-20
Kennedy Keith
Chief Operating Officer
2026-02-02
Hanna John Walter JR
President and CEO
$217K 2026-04-16
Novack Jeffrey Adam
Secretary and General Counsel
$91K 2026-04-06
Meng Jessica
Chief Commercial Officer
2026-04-01
SMITH NATHAN
Chief Financial Officer
2026-02-02